NAHSV Healthlinko Private Limited has entered its second year of operations after completing a foundational year marked by revenue growth, patient expansion, profitable operations, and international partnership development led by its flagship brand, MediFyr.
Since its launch in April 2025, the company has focused on building a technology-enabled healthcare ecosystem aimed at improving patient access, strengthening healthcare discovery, and supporting scalable digital solutions across health and wellness.
Over the past year, MediFyr has become the core driver of the company’s growth, currently supporting more than 2,000 patients every month through healthcare coordination and medical access services. This operating momentum contributed to ₹65 lakh in revenue in the final quarter of the previous financial year, reflecting strong early-stage traction for the business.
The company stated that these milestones were achieved while remaining profitable and self-funded, underscoring a growth model built on operating fundamentals rather than external capital.
According to management, building a sustainable foundation in year one has been a strategic priority, allowing the business to focus on long-term scale, execution discipline, and market trust.
Beyond MediFyr, NAHSV Healthlinko has continued expanding a broader portfolio that includes Zerunio, WhatPregnant, HealthSetu and Unikorn, each contributing to the company’s broader digital health strategy.
As the company enters year two, international growth is expected to play an increasingly important role. Through MediFyr, the company has already developed hospital relationships across Turkey, Egypt, Israel, Thailand, UAE and China, supporting the creation of an early global network focused on cross-border healthcare access.
The company said these partnerships form part of a broader strategy to strengthen international patient pathways while expanding MediFyr’s reach beyond domestic markets.
“Our first year was about proving the model, building trust and establishing a foundation,” the company said in a statement. “The next phase is about scale — expanding MediFyr, growing internationally and strengthening the digital infrastructure needed to support long-term growth.”
Management said future priorities include expanding partner networks, growing patient reach, strengthening technology capabilities and accelerating international expansion.With growing traction, a profitable foundation and global partnerships already in place, NAHSV Healthlinko believes it is positioned for its next stage of growth as it enters its second year.
This press release is provided by a third party. The website does not verify its accuracy and is not responsible for its content or any resulting claims.
